Ilić Tatjana, Mitić Igor, Durdević-Mirković Tatjana, Vucković Biljana, Milić Biljana, Popović Milica
Institut za interne bolesti, Klinika za nefrologiju i klinicku imunologiju, Klinicki centar Vojvodine, Novi Sad.
Med Pregl. 2007;60 Suppl 2:128-32.
Adhesion molecules are essential for cellular interactions and are important in the activation and adhesion of cells. Studies have shown that elevated levels of solubile ICAM and VCAM are related to disease activity in patients with various acute and chronic inflammatory diseases. Our aim was to investigate the correlation between the levels of sICAM-1 anti sVCAM-1 and the degree of disease activity and severity of lupus nephritis.
Using the ELISA procedure, we determined the sera levels of sVCAM-1 and sICAM-1 in 80 patients with SLE and in group of 27 healthy volunteers.
Patients with SLE had significantly higher sera levels of adhesion molecules comparing to the controls (p<0.001). There was a high positive correlation between the sera levels of sVCAM-1 and concentration of anti-ds DNA antibodies in patients with SLE (p<0.001), and there was also a negative correlation between the sera levels of sVCAM-1 and concentration of C3 and C4 component of complement (r=-0.64, r=-0.58). In the group of patients with lupus nephritis, significantly higher sera concentrations of sVCAM-1 were detected compared patients without nephritis. Patients with class III and IV kidney changes had significantly higher levels of sVCAM-1 compared to the patients with class II kidney changes. In the group of patients with activity index of kidney changes (AI) over 4 sVCAM-1 the sera levels were significantly higher compared to the group with AI <4.
The sera level of sVCAM-1 is a reliable parameter to evaluate the autoreactivity degree in SLE. In the same time, sVCAM-1 sera level can be used as a reliable marker to evaluate the renal lesion extensivity in SLE.
黏附分子对于细胞间相互作用至关重要,在细胞激活和黏附中发挥重要作用。研究表明,可溶性细胞间黏附分子(ICAM)和血管细胞黏附分子(VCAM)水平升高与多种急慢性炎症性疾病患者的疾病活动度相关。我们的目的是研究可溶性细胞间黏附分子-1(sICAM-1)和可溶性血管细胞黏附分子-1(sVCAM-1)水平与狼疮性肾炎疾病活动度及严重程度之间的相关性。
采用酶联免疫吸附测定(ELISA)法,我们测定了80例系统性红斑狼疮(SLE)患者和27名健康志愿者血清中sVCAM-1和sICAM-1的水平。
与对照组相比,SLE患者血清黏附分子水平显著更高(p<0.001)。SLE患者血清sVCAM-1水平与抗双链DNA抗体浓度之间存在高度正相关(p<0.001),且血清sVCAM-1水平与补体C3和C4成分浓度之间也存在负相关(r=-0.64,r=-0.58)。在狼疮性肾炎患者组中,与无肾炎患者相比,检测到血清sVCAM-1浓度显著更高。Ⅲ级和Ⅳ级肾脏病变患者的sVCAM-1水平显著高于Ⅱ级肾脏病变患者。在肾脏病变活动指数(AI)超过4的患者组中,血清sVCAM-1水平显著高于AI<4的组。
血清sVCAM-1水平是评估SLE自身反应性程度的可靠参数。同时,血清sVCAM-1水平可作为评估SLE肾脏病变范围的可靠标志物。